A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
Eric J. Topol(Scripps Research Institute), Barry S. George, Charles W. Abbottsmith, Richard S. Stack(University of Kent), Kerry L. Lee(Duke University), Bertram Pitt(Bayer (Germany)), Dean J. Kereiakes(Health Net), Richard J. Candela, William W. O’Neill(Henry Ford Health System), Robert M. Califf(Duke University)
Cited by 945
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
Long COVID: major findings, mechanisms and recommendations
|Nature Reviews Microbiology|2023|4k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k